← NOVAVAX INC NVAX
Market Price
$8.05
Market Cap
$1.34B
P/E Ratio
3.12
Revenue (FY 2025)
↑64.7% YoY
$1.12B
3-Yr CAGR: -17.2%
Net Income
↑334.8% YoY
$440.30M
Net Margin: 39.2%
Free Cash Flow
↓-149.4% YoY
-$250.19M
FCF Yield: -18.71%
EPS (Diluted)
↑309.8% YoY
$2.58
Basic: $2.72
Return on Equity
Efficiency
N/A
ROA: 1,642.0%
⚡ N/A due to negative equity (share buybacks or other)
📊 Multi-Year Historical Performance & Trends
Financial Performance History
Revenue, Net Income & Free Cash Flow
Margins Trend (%)
Gross, Operating & Net Margins
Balance Sheet Strength
Cash, Debt & Equity
Cash Flow Generation
Operating Cash Flow vs CapEx vs FCF
📈 Year-over-Year (YoY) Growth History (NVAX)
All monetary values in millions ($M)
⚠️ YoY Data Quality Alert
- FY 2017: Revenue YoY (+103.1%) is identical to Gross Profit YoY (+103.1%). Verify the underlying Revenue and Gross Profit values for FY 2017 and FY 2016.
- FY 2018: Revenue YoY (+10.0%) is identical to Gross Profit YoY (+10.0%). Verify the underlying Revenue and Gross Profit values for FY 2018 and FY 2017.
- FY 2019: Revenue YoY (-45.6%) is identical to Gross Profit YoY (-45.6%). Verify the underlying Revenue and Gross Profit values for FY 2019 and FY 2018.
- FY 2020: Revenue YoY (+2448.5%) is identical to Gross Profit YoY (+2448.5%). Verify the underlying Revenue and Gross Profit values for FY 2020 and FY 2019.
- FY 2021: Revenue YoY (+141.0%) is identical to Gross Profit YoY (+141.0%). Verify the underlying Revenue and Gross Profit values for FY 2021 and FY 2020.
| Fiscal Year | Revenue | Revenue YoY | Gross Profit | Net Income | Net Inc YoY | Diluted EPS | EPS YoY | Op. Cash Flow | Free Cash Flow | FCF YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2016 | $15.4M | — | $9.7M | $-280.0M | — | $-1.03 | — | $-255.5M | $-273.7M | — |
| FY 2017 | $31.2M | +103.1% | $19.7M | $-183.8M | +34.4% | $-0.63 | +38.8% | $-138.7M | $-142.9M | +47.8% |
| FY 2018 | $34.3M | +10.0% | $21.7M | $-184.7M | -0.5% | $-0.50 | +20.6% | $-184.8M | $-186.2M | -30.3% |
| FY 2019 | $18.7M | -45.6% | $11.8M | $-132.7M | +28.2% | $-5.51 | -1,002.0% | $-136.6M | $-138.5M | +25.6% |
| FY 2020 | $475.6M | +2,448.5% | $300.9M | $-418.3M | -215.2% | $-7.27 | -31.9% | $-42.5M | $-97.2M | +29.8% |
| FY 2021 | $1,146.3M | +141.0% | $725.2M | $-1,743.8M | -316.9% | $-23.44 | -222.4% | $322.9M | $265.5M | +373.2% |
| FY 2022 | $1,981.9M | +72.9% | $1,079.2M | $-657.9M | +62.3% | $-8.42 | +64.1% | $-415.9M | $-505.0M | -290.2% |
| FY 2023 | $983.7M | -50.4% | $639.9M | $-545.1M | +17.2% | $-5.41 | +35.7% | $-714.0M | $-767.7M | -52.0% |
| FY 2024 | $682.2M | -30.7% | $479.4M | $-187.5M | +65.6% | $-1.23 | +77.3% | $-87.3M | $-100.3M | +86.9% |
| FY 2025 | $1,123.5M | +64.7% | $1,050.4M | $440.3M | +334.8% | $2.58 | +309.8% | $-244.6M | $-250.2M | -149.4% |
Valuation
Market Price
$8.05
Market Cap
$1.34B
Enterprise Value
N/A
P/E Ratio
3.12
P/B Ratio
N/A
FCF Yield
-18.71%
Dividend Yield
N/A
Shares Outstanding
Profitability & Margins
Gross Margin
93.50%
Operating Margin
40.30%
Net Margin
39.19%
Return on Equity (ROE)
N/A (Negative Equity)
Return on Assets (ROA)
1,642.00%
Asset Turnover
41.90x
Revenue 3-Yr CAGR
-17.24%
Financial Health & Liquidity
Current Ratio
0.25
Cash Ratio
2.25
Debt / Equity
N/A
Debt / Assets
N/A
Cash & Equivalents
$240.63M
Total Debt
N/A
Book Value / Share
$-0.78
Cash Flow Efficiency
Operating Cash Flow
-$244.63M
Capital Expenditures (CapEx)
$5.56M
Free Cash Flow
-$250.19M
OCF / Revenue
-21.77%
FCF / Revenue
-22.27%
FCF 3-Yr CAGR
N/A
Per Share Metrics
EPS (Diluted)
$2.58
EPS (Basic)
$2.72
Dividends / Share
N/A
Book Value / Share
$-0.78
EPS YoY Growth
309.76%
Balance Sheet (FY 2025)
Total Assets
$26.82M
Total Liabilities
$107.17M
Stockholders' Equity
-$127.75M
Current Assets
$26.82M
Current Liabilities
$107.17M